Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Most cases are mild and self-limited, especially with food timing and hydration adjustments
Active, not recruiting Diabetes Mellitus, Type 2 Diabetic Peripheral Neuropathy Drug: CagriSema (Cagrilintide B and Semaglutide I) Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight
For most patients, symptoms improve as the body adapts over time
Key Effects: Mimicking Incretin Hormones Functions like endogenous GLP-1 to regulate metabolism and appetite
Keep an eye on your blood sugar levels if you are using semaglutide for diabetes, as they can help guide dosage decisions
